Western Europe To Remain A Prime Clinical Research Destination

BMI Core View: Governments in developed states need to work to maintain the countries' long-term attractiveness as sites for clinical trials, especially as the cost of conducting clinical research is forecast to rise. Data confirms that North America and Western Europe have been the leading destinations in terms of trial numbers; however, trends show a shift toward conducting trials in Central & Eastern Europe (CEE), as well as increasing rates of patient recruitment for clinical trials in Latin America and Asia. The impetus for this shift includes greater access to drug-naïve patients, low labour costs and a closer relationship between

To read the full article, please choose one of the following options: